Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | INBX |
---|---|---|
09:32 ET | 2347 | 34.97 |
09:34 ET | 215 | 34.96 |
09:36 ET | 900 | 35.12 |
09:45 ET | 100 | 34.99 |
09:52 ET | 200 | 34.97 |
09:54 ET | 100 | 35.11 |
09:56 ET | 3288 | 35.08 |
09:57 ET | 314 | 35.15 |
10:01 ET | 216 | 35.13 |
10:08 ET | 306 | 35.1 |
10:12 ET | 184 | 35.02 |
10:19 ET | 100 | 35.04 |
10:24 ET | 217 | 35.12 |
10:26 ET | 1119 | 35.14 |
10:32 ET | 272 | 35.156 |
10:39 ET | 146 | 35.2 |
10:42 ET | 400 | 35.15 |
10:53 ET | 1165 | 35.2 |
10:55 ET | 862 | 35.2 |
11:02 ET | 172 | 35.175 |
11:04 ET | 200 | 35.125 |
11:29 ET | 952 | 35.2 |
11:31 ET | 10561 | 35.2 |
11:33 ET | 6897 | 35.2 |
11:47 ET | 527 | 35.187 |
11:49 ET | 628 | 35.21 |
11:54 ET | 200 | 35.24 |
12:00 ET | 700 | 35.23 |
12:02 ET | 200 | 35.24 |
12:07 ET | 300 | 35.19 |
12:09 ET | 257 | 35.19 |
12:21 ET | 1852 | 35.1104 |
12:23 ET | 406 | 35.22 |
12:25 ET | 200 | 35.12 |
12:30 ET | 134 | 35.07 |
12:36 ET | 100 | 35.09 |
12:54 ET | 104 | 35.115 |
12:56 ET | 200 | 35.08 |
12:57 ET | 200 | 35.12 |
01:03 ET | 200 | 35.05 |
01:17 ET | 100 | 35.1 |
01:26 ET | 600 | 35.08 |
01:28 ET | 751 | 35.13 |
01:39 ET | 100 | 35.03 |
01:50 ET | 200 | 35.05 |
01:55 ET | 400 | 35.06 |
01:57 ET | 600 | 35.06 |
02:02 ET | 100 | 35.09 |
02:06 ET | 200 | 35.09 |
02:08 ET | 1043 | 35.11 |
02:09 ET | 341 | 35.13 |
02:18 ET | 134 | 35.16 |
02:22 ET | 200 | 35.09 |
02:24 ET | 134 | 35.07 |
02:26 ET | 100 | 35.095 |
02:29 ET | 112 | 35.111 |
02:31 ET | 100 | 35.13 |
02:36 ET | 200 | 35.15 |
02:40 ET | 200 | 35.115 |
02:42 ET | 500 | 35.13 |
02:49 ET | 200 | 35.14 |
02:51 ET | 400 | 35.125 |
02:56 ET | 100 | 35.13 |
03:02 ET | 300 | 35.15 |
03:03 ET | 900 | 35.145 |
03:12 ET | 203 | 35.12 |
03:16 ET | 200 | 35.075 |
03:23 ET | 6938 | 35.11 |
03:25 ET | 466 | 35.13 |
03:27 ET | 296 | 35.11 |
03:30 ET | 397 | 35.14 |
03:32 ET | 1000 | 35.17 |
03:34 ET | 300 | 35.11 |
03:36 ET | 700 | 35.12 |
03:38 ET | 557 | 35.06 |
03:39 ET | 700 | 35.06 |
03:41 ET | 200 | 35.065 |
03:43 ET | 500 | 35.065 |
03:45 ET | 1400 | 35.075 |
03:48 ET | 407 | 35.04 |
03:50 ET | 1091 | 35.05 |
03:52 ET | 2155 | 35.01 |
03:54 ET | 11129 | 34.98 |
03:56 ET | 4010 | 35.01 |
03:57 ET | 3590 | 35.01 |
03:59 ET | 3934 | 34.96 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Inhibrx Inc | 1.7B | -7.0x | --- |
Akero Therapeutics Inc | 1.7B | -8.9x | --- |
Autolus Therapeutics PLC | 1.7B | -5.3x | --- |
Kura Oncology Inc | 1.6B | -10.2x | --- |
Edgewise Therapeutics Inc | 1.7B | -11.6x | --- |
Morphic Holding Inc | 1.8B | -10.1x | --- |
Inhibrx, Inc. is a clinical-stage biopharmaceutical company, which is focused on developing a broad pipeline of novel biologic therapeutic candidates. The Company’s pipeline is focused on oncology and orphan diseases. Its clinical pipeline includes therapeutic candidates, such as INBRX-101, and INBRX-109. INBRX-101 is an engineered recombinant human alpha-1 antitrypsin fragment crystallizable (AAT-Fc) fusion protein therapeutic candidate that the Company is developing for the treatment of patients with Alpha-1 Antitrypsin Deficiency (AATD) and acute Graft-versus -host-disease (aGvHD). AATD is an inherited disease that causes an increased risk of developing pulmonary disease defined by progressive loss of lung tissue and function and is associated with decreased life expectancy. INBRX-109 is an engineered tetravalent therapeutic candidate targeting death-receptor 5 (DR5), a TNFRSF member, also known as tumor necrosis factor-related apoptosis-inducing ligand or TRAIL receptor 2.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.7B |
---|---|
Revenue (TTM) | $1.8M |
Shares Outstanding | 47.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.92 |
EPS | $-5.03 |
Book Value | $0.92 |
P/E Ratio | -7.0x |
Price/Sales (TTM) | 920.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,178.94% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.